NO984513D0 - Benzyl(iden)-laktam-derivater, deres fremstilling og deres anvendelse som selektive (ant)agonister for 5-HT1A- og 5-HT1D-reseptorer - Google Patents

Benzyl(iden)-laktam-derivater, deres fremstilling og deres anvendelse som selektive (ant)agonister for 5-HT1A- og 5-HT1D-reseptorer

Info

Publication number
NO984513D0
NO984513D0 NO984513A NO984513A NO984513D0 NO 984513 D0 NO984513 D0 NO 984513D0 NO 984513 A NO984513 A NO 984513A NO 984513 A NO984513 A NO 984513A NO 984513 D0 NO984513 D0 NO 984513D0
Authority
NO
Norway
Prior art keywords
ht1a
iden
ant
agonists
benzyl
Prior art date
Application number
NO984513A
Other languages
English (en)
Other versions
NO984513L (no
NO312957B1 (no
Inventor
Harry R Howard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO984513D0 publication Critical patent/NO984513D0/no
Publication of NO984513L publication Critical patent/NO984513L/no
Publication of NO312957B1 publication Critical patent/NO312957B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19984513A 1996-03-29 1998-09-28 Benzyl(iden)-laktamderivater, anvendelse derav og farmasöytisk sammensetning NO312957B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1513496P 1996-03-29 1996-03-29
PCT/IB1997/000076 WO1997036867A1 (en) 1996-03-29 1997-02-03 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors

Publications (3)

Publication Number Publication Date
NO984513D0 true NO984513D0 (no) 1998-09-28
NO984513L NO984513L (no) 1998-09-28
NO312957B1 NO312957B1 (no) 2002-07-22

Family

ID=21769713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984513A NO312957B1 (no) 1996-03-29 1998-09-28 Benzyl(iden)-laktamderivater, anvendelse derav og farmasöytisk sammensetning

Country Status (40)

Country Link
US (2) US6462048B2 (no)
EP (1) EP0894085B1 (no)
JP (1) JP3118467B2 (no)
KR (1) KR100305071B1 (no)
CN (1) CN1128788C (no)
AP (1) AP824A (no)
AR (1) AR006390A1 (no)
AT (1) ATE302182T1 (no)
AU (1) AU706839B2 (no)
BG (1) BG64176B1 (no)
BR (1) BR9708581A (no)
CA (1) CA2249603A1 (no)
CO (1) CO4650033A1 (no)
CZ (1) CZ293628B6 (no)
DE (1) DE69733996T2 (no)
DZ (1) DZ2198A1 (no)
EA (1) EA001485B1 (no)
ES (1) ES2246058T3 (no)
HK (1) HK1019446A1 (no)
HN (1) HN1997000023A (no)
HR (1) HRP970175A2 (no)
HU (1) HUP9902160A3 (no)
ID (1) ID17781A (no)
IL (1) IL125377A (no)
IS (1) IS4813A (no)
MA (1) MA26425A1 (no)
MY (1) MY118498A (no)
NO (1) NO312957B1 (no)
NZ (1) NZ325914A (no)
OA (1) OA10879A (no)
PL (1) PL329170A1 (no)
SK (1) SK131498A3 (no)
TN (1) TNSN97056A1 (no)
TR (1) TR199801929T2 (no)
TW (1) TW413679B (no)
UA (1) UA70284C2 (no)
UY (1) UY24498A1 (no)
WO (1) WO1997036867A1 (no)
YU (1) YU11997A (no)
ZA (1) ZA972690B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH041367U (no) * 1990-04-13 1992-01-08
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6696448B2 (en) 1996-06-05 2004-02-24 Sugen, Inc. 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
US6423708B1 (en) * 1996-09-30 2002-07-23 Pfizer Inc Aralkyl and aralkylidene heterocyclic lactams and imides
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
ES2225031T3 (es) * 1999-12-29 2005-03-16 Pfizer Products Inc. Compuestos de 3-((2-piperazinil-fenil)metil)-1-(4-(trifluorometil)fenil)-2-pirrolidinona opticamente activos como antagonistas selectivos del receptor de 5-ht1d.
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
BR0213185A (pt) 2001-10-10 2004-09-14 Sugen Inc Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase
US8575169B2 (en) 2001-10-29 2013-11-05 Versi Group, Llc Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
ATE533745T1 (de) * 2004-03-17 2011-12-15 Pfizer Prod Inc Neue benzyl(iden)-lactam-derivate
MXPA06013163A (es) * 2004-05-11 2007-02-13 Pfizer Prod Inc Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b.
JP2008500381A (ja) * 2004-05-21 2008-01-10 ファイザー・プロダクツ・インク ピラジニルメチルラクタム誘導体
CA2571443A1 (en) * 2004-06-25 2006-01-05 Pfizer Products Inc. Pyridyl piperazines for the treatment of cns disorders
ES2371927T3 (es) * 2005-01-13 2012-01-11 Ge Healthcare Limited Compuestos de bencil-lactama marcados con 11c y su uso como agentes de obtención de imágenes.
WO2006106416A1 (en) * 2005-04-08 2006-10-12 Pfizer Products Inc. PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN
JP2008543829A (ja) * 2005-06-17 2008-12-04 ファイザー・プロダクツ・インク セロトニン受容体アンタゴニストとしての１−［６−（１−エチル−１−ヒドロキシ−プロピル）−ピリジン−３−イル］−３−［２−（４−メチル−ピペラジン−１−イル）−ベンジル］−ピロリジン−２−オンの代謝産物
WO2007012964A1 (en) * 2005-07-25 2007-02-01 Pfizer Products Inc. Preparation of alkylpiperazinylphenyl compounds by classical resolution
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
WO2007026224A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. 5-ht1b antagonist composition for depression, anxiety and cognition
US20070096411A1 (en) * 2005-11-02 2007-05-03 Rempe Gary L Ii Device for retaining a kneeling rider on a gliding board
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
SI3344248T1 (sl) 2015-09-02 2022-07-29 Trevena, Inc. 6-členske aza-heterociklične spojine za modulacijo, ki vsebujejo delta-opioidne receptorje, metode uporabe in izdelave
EP3582779B1 (en) 2017-02-17 2024-04-17 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
JP7185633B2 (ja) 2017-02-17 2022-12-07 トレベナ・インコーポレイテッド ７員アザ複素環を含有するデルタ－オピオイド受容体調節化合物、その使用方法及び製造方法
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078062A (en) * 1976-10-28 1978-03-07 E. R. Squibb & Sons, Inc. Substituted 2H-1,4-benzothiazin-3(4H)-ones
JPS62116557A (ja) * 1985-11-15 1987-05-28 Takeda Chem Ind Ltd 置換ベンジルラクタム類
US5189179A (en) 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
ES2162792T3 (es) 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
JP3208140B2 (ja) * 1991-10-11 2001-09-10 デュポン・ファーマシュウティカルズ・カンパニー レトロウイルスプロテアーゼ阻害剤として有用な置換された環状カルボニルおよびその誘導体
US5436246A (en) 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6467084B1 (en) * 1999-12-16 2002-10-15 Emware, Inc. Systems and methods for reprogramming an embedded device with program code using relocatable program code

Also Published As

Publication number Publication date
HN1997000023A (es) 1997-06-05
DE69733996D1 (de) 2005-09-22
BG64176B1 (bg) 2004-03-31
JP3118467B2 (ja) 2000-12-18
TNSN97056A1 (fr) 2005-03-15
NO984513L (no) 1998-09-28
OA10879A (en) 2001-10-05
CN1128788C (zh) 2003-11-26
CO4650033A1 (es) 1998-09-03
ATE302182T1 (de) 2005-09-15
MY118498A (en) 2004-11-30
CN1214043A (zh) 1999-04-14
ID17781A (id) 1998-01-29
US6924289B2 (en) 2005-08-02
MA26425A1 (fr) 2004-12-20
IL125377A0 (en) 1999-03-12
HK1019446A1 (en) 2000-02-11
EA199800771A1 (ru) 1999-06-24
ZA972690B (en) 1998-09-28
NO312957B1 (no) 2002-07-22
BR9708581A (pt) 1999-08-03
TW413679B (en) 2000-12-01
BG102791A (en) 1999-11-30
WO1997036867A1 (en) 1997-10-09
EP0894085B1 (en) 2005-08-17
UA70284C2 (en) 2004-10-15
ES2246058T3 (es) 2006-02-01
AP9700955A0 (en) 1997-04-30
AU706839B2 (en) 1999-06-24
IS4813A (is) 1998-07-29
UY24498A1 (es) 2000-09-29
TR199801929T2 (xx) 1998-12-21
IL125377A (en) 2005-07-25
EA001485B1 (ru) 2001-04-23
US20030027812A1 (en) 2003-02-06
US20020028821A1 (en) 2002-03-07
KR100305071B1 (ko) 2001-12-12
AR006390A1 (es) 1999-08-25
AU1317097A (en) 1997-10-22
YU11997A (sh) 1999-09-27
CA2249603A1 (en) 1997-10-09
EP0894085A1 (en) 1999-02-03
PL329170A1 (en) 1999-03-15
CZ305298A3 (cs) 1999-07-14
NZ325914A (en) 1999-09-29
HRP970175A2 (en) 1998-12-31
AP824A (en) 2000-04-28
DZ2198A1 (fr) 2002-12-02
SK131498A3 (en) 2000-09-12
HUP9902160A2 (hu) 1999-11-29
US6462048B2 (en) 2002-10-08
DE69733996T2 (de) 2006-07-20
JPH11506472A (ja) 1999-06-08
KR20000005083A (ko) 2000-01-25
CZ293628B6 (cs) 2004-06-16
HUP9902160A3 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
NO984513D0 (no) Benzyl(iden)-laktam-derivater, deres fremstilling og deres anvendelse som selektive (ant)agonister for 5-HT1A- og 5-HT1D-reseptorer
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
AU4337699A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT4 receptors
DK1119557T3 (da) Indeno-, naphto- og benzocyclohepta-dihydrothiazolderivater, fremstilling deraf og anvendelse deraf som anorektiske medikamenter
DK0847388T3 (da) Heterocyklisk substituerede biphenylamidderivater, fremstilling heraf og anvendelse heraf som fungicider
NO20012058D0 (no) 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
NO20021719L (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
IS6566A (is) Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO996115D0 (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO20006460D0 (no) 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse
NO963117D0 (no) Indol-derivater som 5-HT1-agonister
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
NO971136D0 (no) Aminoalkyl- og acylaminoaklyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister
NO20004144D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister
NO20004271D0 (no) Benzylpiperazinyl- og benzylpiperidinyl etanonderivater, deres fremstilling og deres anvendelse som dopamin D4 reseptorantagonister
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO20001937D0 (no) 2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D)
NO20002959L (no) Echinocandinderivater, fremgangsmÕte for fremstilling av slike og deres anvendelse som anti-soppmidler
DK1076651T3 (da) Substituerede sulfonylcyanamider, fremgangsmåde til fremstilling heraf og anvendelsen heraf som lægemidler
AU2883397A (en) 5-alkoxy-tryptamine derivatives, their preparation and their use as 5-ht1d receptor agonists
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse
DK1015449T3 (da) (Hetero)arylsulfonamidderivater, deres fremstilling og deres anvendelse som faktor Xa-inhibitorer